Emergence of Haemophilus influenzae Strains in the Nasopharynx of Children with Tuberculosis by Martynova, Alina V. et al.
Hindawi Publishing Corporation
Pulmonary Medicine
Volume 2011, Article ID 420284, 3 pages
doi:10.1155/2011/420284
Clinical Study
EmergenceofHaemophilusinfluenzae Strainsin
theNasopharynx ofChildrenwith Tuberculosis
Alina V.Martynova,1 LarisaA.Balabanova,2 and AlexeiPruschinskyi1
1Epidemiology Department, State Vladivostok Medical University, Ostryakova 2, Vladivostok, Russia
2Paciﬁc Institute of Bioorganic Chemistry (PIBOC), Russia
Correspondence should be addressed to Alina V. Martynova, anilina@freemail.ru
Received 16 March 2011; Revised 9 May 2011; Accepted 9 May 2011
Academic Editor: N. Ambrosino
Copyright © 2011 Alina V. Martynova et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Being rigorously studied, epidemiology aspects of Haemophilus inﬂuenzae carriage are still remaining unclear. Especially it
concerns such a group as children with low immune status and also such group as children with tuberculosis infection. We
examined nasopharyngeal tract of children with tuberculosis infection in remission and checked how often these children are
carriers of Haemophilus inﬂuenzae strains. Also we gained microbiology characteristics of the isolates and deﬁned the clinical
signiﬁcance of H. inﬂuenzae carriage in development of opportunistic infections in children with the tuberculosis infection.
1.Introduction
Despite improvements in diagnosis, treatment,and preven-
tive measures, tuberculosis remains an important cause of
morbidity globally.
In the Primorye Region of far east Russia (population
2000.000), the incidence of tuberculosis in 2008 was 105.7
per 100.000 and with a prevalence of 222 per 100.000. For
children under 17 years, the incidence of tuberculosis was
36.6per100.000.In2008,therewere108casesoftuberculosis
in children under 11 years, and 83 cases in children from
11 to 17 years (Federal Morbidity Report, 2009). Mortality
increased by 20.7% compared to 2000. In the pediatric
population, pulmonary tuberculosis accounted for 90.9% of
all tuberculosis in 2008, up from 72.7% in 1999.
It was recognized that children treated for tubercu-
losis were more often ill with other bacterial respiratory
tract infections than children without such comorbidity.
There are several possible contributing factors to this,
for example, impaired immune status, malnutrition, and
low socioeconomical status of their family. However, other
important factors could be the regular antimicrobial (anti-
tuberculosis) chemotherapy they receive or attendance at the
Pediatric Tuberculosis Center for anything between 20 and
180 days, according to the current tuberculosis treatment
protocol.Asthe main focusfor such patientsisthe treatment
of tuberculosis, the problem of other bacterial respiratory
tract infections could be underestimated.
There are some data on the carriage of bacterial respira-
tory tract pathogens in children with various comorbidities
[1–5], but little information on the carriage of H.inﬂuenzae
in children with tuberculosis or children from closed com-
munities [5, 6].
Aim. We aim to study the prevalance of H. inﬂuenzae in
the nasopharynx of children with tuberculosis and to assess
antimicrobial susceptibility of these bacteria.
2.Materialsand Methods
We examined 85 children from the Pediatric Tuberculosis
Center (Group 1), all of whom had taken antituber-
culosis chemotherapy within the previous 1.5-2 months,
with rifampicin, isoniazid, ethambutol, and streptomycin
(according to WHO recommendations). They had received
their treatment in the Pediatris Tuberculosis Center sana-
t o r i u mf o ru pt o3m o n t h s .O ft h e8 5p a t i e n t si nG r o u p
1, 36 patients (42.3%) had tuberculosis intoxication, 28
patients (32.9%) had post-BCG complications, and 212 Pulmonary Medicine
Table 1: Strains of H. inﬂuenzae isolated from patients with tuberculosis (Group 1) and children without tuberculosis (Gorup 2).
No
patients Strains Patients with one
strain
Patients withmultiple
isolates
Group 1
(children with tuberculosis) 43 51 26 (60.4%) 17 (39.5%)
Group 2
(children without tuberculosis, control group) 18 23 13 (18.57%) 5 (7.1%)
patients (24.7%) had extrapulmonary tuberculosis. Group
1 consisted of 41 patients (48.2%) under 5 years of age, 28
patients (32.94%) aged 6–10 years, and 16 patients (18.8%)
aged 11–15 years. All Group 1 patients took low doses of
rifampicin as recommendedbythe PublicHealthMinistry. A
control group (Group 2) consisted of age-matched children
withouttuberculosisattendingthepediatricsanatoriumwith
gastrointestinal pathology (70 patients).
Nasal- and oropharyngeal swabs were taken from both
groups of children using nylon ﬂocked swabs and a liquid
transport medium, which were plated onto an appropriate
medium (Chocolate agar, Biorad, USA).
The identiﬁcation of H. inﬂuenzae strains was conﬁrmed
by the use of X factor (hemin), V factor (nicotinamide-
adenine dinucleotide), and X+V factor disks (Lachema,
India) on nutrient agar plates according to the manufac-
turer’s instructions. Serotypes were determined by means
of a coagglutination technique with antiserum against
serotype bcapsular polysaccharide and polyvalent antiserum
for serotypes a, c, d, e, and f (Phadebact Hitypes a, c–
f, Boule Diagnostics, Sweden). The following six strains
were used as positive controls for serotypes a, b, c, d, e
and f, respectively:ATCC 9006, ATCC 10211, ATCC 9007,
ATCC 9332, ATTC 8142 and ATCC 9833. Initial typing
results were conﬁrmed by typing all strains by PCR by
the method of Maarouﬁ [7] .T h ep r e s e n c eo fβ-lactamase
was detected with nitroceﬁn disks (BBL Ceﬁnase, Becton
Dickinson, Cockeysville, Md, USA). Antimicrobial suscep-
tibility was determined by disk diﬀusion and microdilution
methods according to CLSI (Clinical and Laboratory Stan-
dards Institute) standards and breakpoints. For macrolides
(clarithromycin), resistance was taken as MIC ≥32mg/L,
for rifampicin, it was about ≥4mg/L, and for ampicillin it
was ≥4mg/L. The study was approved by the Local Human
Investigations Committee. Data were analysed according
to common statistical methods, including incidence and
prevalence analysis and odds ratio (OR) calculating for risk
factors analysis.
3.Results
More than 60% of the children with tuberculosis had acute
pathology of upper and lower respiratory tract of nontuber-
culosisetiologymorethan8timesperyear.Childrenyounger
of 5 years with tuberculosis had upper respiratory tract
pathology more often (OR = 9.0) than children of the same
age without tuberculosis. In children without tuberculosis,
there were only 8 who had acute pathology of upper and
lower respiratory tract more than 5 times per year).
A total of 51 strains of H.inﬂuenzae were isolated from
43 patients in Group 1, and 23 strains from 18 patients in the
controlgroup(Group 2).The resultsare presented inTable 1.
Children from Group 1 carried H. inﬂuenzae more
often (50.5%, 43 patients) than children from Group 2
(25.5%18patients).Itisnotable,however,thatantimicrobial
consumption was much higher in children of the 1st Group
(P = 0.003). Children in Group 1 often harbored more than
1s t r a i no fH. inﬂuenzae.
From Group 1 children, there were 51 strains isolated
from 43 patients. Only onestrain in26 patients(60.4%),and
2 and more strains in 17 patients (39.5%). From Group 2
children, there was a single strain from13 patients (18.57%)
and 2 or more strains from 5 patients (7,1%) (P<0.05).
The prevalence of diﬀerent serotypes of Haemophilus
genus was also diﬀerent in children from Group 1, compared
to children in Group 2. In Group 1, 54% (28 strains) were
nontypable,and46%(23strains)were typable H.inﬂuenzae.
In Group 2, 24,8% (17 strains) were typable, and only 8.57%
(6strains) werenontypablestrains ofH.inﬂuenzae.InGroup
1 the types were type B 47.82 % (11 isolates), type A 13.04
% (3 strains), type F 17.31% (4 strains), type D 8.69% (2
strains), and type C 13.04% (3strains). In Group 2, the types
were 15,7% (11isolates) of type B, 2.85% (2 isolates) of type
D, 2.85% (2 isolates) of type C, and 2.85% (on 1 isolate) of
types E and F.
Regarding beta-lactamase production, there were 12
beta-lactamase-positive strains (23.5% ) in Group 1 and just
2 beta-lactamase-positive strains (2.85%) in Group 2. One
explanation for this ﬁnding is the higher consumption of
antimicrobial agents in Group 1 children.
The strains from Group 1 children (total 51 iso-
lates) were resistant to rifampicin 15.6% (8 strains, MIC>
8mg/L), ampicillin 31.37% (16 strains, MIC >8mg/L),
clarithromycin 21.5% (11 strains, MIC >16mg/L), cotri-
moxazole 9.08% (5 strains, MIC >4mg/L).
Thestrains fromGroup1children(total23isolates)were
resistan to ampicillin 1.42% (1 strain, MIC >2mg/L),and
there was no resistance to rifampicin.
F u r t h e ri n v e s t i g a t i o n sr e v e a l e dt h a tp a t i e n t sw h oc a r r i e d
H. inﬂuenzae suﬀered from rhinosinusitis for an average
of 136 days per year and from otitis media for 92 days
per year. Children with tuberculosis but without carriage of
H. inﬂuenzae suﬀered from otitis media for 14 days per year.
4.Conclusion
The carriage of potential bacterial respiratory pathogens
in children treated for tuberculosis is underestimated.Pulmonary Medicine 3
The application of molecular epidemiology methods may
determine if these organisms are hospital or community
acquired.
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